|
US99823A
(en)
|
|
1870-02-15 |
|
Improved indigo soap |
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
|
US5766903A
(en)
|
1995-08-23 |
1998-06-16 |
University Technology Corporation |
Circular RNA and uses thereof
|
|
US5849727A
(en)
|
1996-06-28 |
1998-12-15 |
Board Of Regents Of The University Of Nebraska |
Compositions and methods for altering the biodistribution of biological agents
|
|
WO1998051278A2
(en)
|
1997-05-14 |
1998-11-19 |
Inex Pharmaceuticals Corporation |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030077829A1
(en)
|
2001-04-30 |
2003-04-24 |
Protiva Biotherapeutics Inc.. |
Lipid-based formulations
|
|
KR101164256B1
(ko)
|
2003-09-15 |
2012-07-10 |
프로티바 바이오쎄라퓨틱스, 인코포레이티드 |
폴리에틸렌글리콜 개질된 지질 화합물 및 그의 용도
|
|
JP4380411B2
(ja)
|
2004-04-30 |
2009-12-09 |
澁谷工業株式会社 |
滅菌方法
|
|
EP2992902A1
(en)
|
2004-12-27 |
2016-03-09 |
Silence Therapeutics GmbH |
Lipid complexes coated with peg and their uses
|
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
|
US7451428B2
(en)
|
2005-02-24 |
2008-11-11 |
Texas Instruments Incorporated |
Merging sub-resolution assist features of a photolithographic mask through the use of a merge bar
|
|
US20080042973A1
(en)
|
2006-07-10 |
2008-02-21 |
Memsic, Inc. |
System for sensing yaw rate using a magnetic field sensor and portable electronic devices using the same
|
|
EP2224912B1
(en)
|
2008-01-02 |
2016-05-11 |
TEKMIRA Pharmaceuticals Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
CA2721333C
(en)
|
2008-04-15 |
2020-12-01 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
WO2009132131A1
(en)
|
2008-04-22 |
2009-10-29 |
Alnylam Pharmaceuticals, Inc. |
Amino lipid based improved lipid formulation
|
|
CN102014880A
(zh)
|
2008-05-01 |
2011-04-13 |
Nod药物公司 |
治疗性磷酸钙颗粒及其制备和使用方法
|
|
JP5777519B2
(ja)
|
2008-10-09 |
2015-09-09 |
テクミラ ファーマシューティカルズ コーポレイション |
改良されたアミノ脂質および核酸の送達方法
|
|
SG10201809460SA
(en)
|
2008-10-20 |
2018-11-29 |
Alnylam Pharmaceuticals Inc |
Compositions and methods for inhibiting expression of transthyretin
|
|
WO2010053572A2
(en)
|
2008-11-07 |
2010-05-14 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
WO2010054384A1
(en)
|
2008-11-10 |
2010-05-14 |
Alnylam Pharmaceuticals, Inc. |
Lipids and compositions for the delivery of therapeutics
|
|
DK2355851T3
(en)
|
2008-11-10 |
2018-06-25 |
Arbutus Biopharma Corp |
Newly known lipids and compositions for release of therapeutic agents
|
|
WO2010084371A1
(en)
*
|
2009-01-26 |
2010-07-29 |
Mitoprod |
Novel circular interfering rna molecules
|
|
CA2764609C
(en)
|
2009-06-10 |
2018-10-02 |
Alnylam Pharmaceuticals, Inc. |
Improved cationic lipid of formula i
|
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
|
JP5766188B2
(ja)
|
2009-07-01 |
2015-08-19 |
プロチバ バイオセラピューティクス インコーポレイティッド |
固形腫瘍に治療剤を送達するための脂質製剤
|
|
EP2467357B1
(en)
|
2009-08-20 |
2016-03-30 |
Sirna Therapeutics, Inc. |
Novel cationic lipids with various head groups for oligonucleotide delivery
|
|
EP2506879A4
(en)
|
2009-12-01 |
2014-03-19 |
Protiva Biotherapeutics Inc |
PREPARATIONS OF SNALP CONTAINING ANTIOXIDANTS
|
|
CA2783372C
(en)
|
2009-12-07 |
2019-07-16 |
Muthiah Manoharan |
Compositions for nucleic acid delivery
|
|
EP2525781A1
(en)
|
2010-01-22 |
2012-11-28 |
Schering Corporation |
Novel cationic lipids for oligonucleotide delivery
|
|
WO2011097480A1
(en)
|
2010-02-05 |
2011-08-11 |
University Of Louisville Research Foundation, Inc. |
Exosomal compositions and methods for the treatment of disease
|
|
EP2569276B1
(en)
|
2010-05-12 |
2021-02-24 |
Arbutus Biopharma Corporation |
Novel cationic lipids and methods of use thereof
|
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
|
CA2800401C
(en)
|
2010-06-03 |
2020-09-15 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
DK2575767T3
(en)
|
2010-06-04 |
2017-03-13 |
Sirna Therapeutics Inc |
HOWEVER UNKNOWN LOW MOLECULAR CATIONIC LIPIDS TO PROCESS OIGONUCLEOTIDES
|
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
US20130323269A1
(en)
|
2010-07-30 |
2013-12-05 |
Muthiah Manoharan |
Methods and compositions for delivery of active agents
|
|
BR112013004865A2
(pt)
|
2010-08-31 |
2016-06-07 |
Novartis Ag |
lípidos adequados para entrega lipossomal de codificadores de proteínas rna
|
|
WO2012040184A2
(en)
|
2010-09-20 |
2012-03-29 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight cationic lipids for oligonucleotide delivery
|
|
CA2811430A1
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
|
US20120101478A1
(en)
|
2010-10-21 |
2012-04-26 |
Allergan, Inc. |
Dual Cartridge Mixer Syringe
|
|
EP3485913A1
(en)
|
2010-10-21 |
2019-05-22 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
|
SG190784A1
(en)
|
2010-11-09 |
2013-07-31 |
Fujian Haixi Pharmaceuticals Inc |
Compound for increasing kinase active and application thereof
|
|
US9617461B2
(en)
|
2010-12-06 |
2017-04-11 |
Schlumberger Technology Corporation |
Compositions and methods for well completions
|
|
JP5902197B2
(ja)
|
2011-01-11 |
2016-04-13 |
アルニラム・ファーマシューティカルズ・インコーポレーテッド |
Ｐｅｇ化脂質および薬剤送達のためのそれらの使用
|
|
WO2012162210A1
(en)
|
2011-05-26 |
2012-11-29 |
Merck Sharp & Dohme Corp. |
Ring constrained cationic lipids for oligonucleotide delivery
|
|
WO2013016058A1
(en)
|
2011-07-22 |
2013-01-31 |
Merck Sharp & Dohme Corp. |
Novel bis-nitrogen containing cationic lipids for oligonucleotide delivery
|
|
AU2012315965A1
(en)
|
2011-09-27 |
2014-04-03 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted PEGylated lipids
|
|
MX363734B
(es)
|
2011-10-27 |
2019-03-29 |
Massachusetts Inst Technology |
Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco.
|
|
US20140308212A1
(en)
|
2011-11-07 |
2014-10-16 |
University Of Louisville Research Foundation, Inc. |
Edible plant-derived microvesicle compositions for diagnosis and treatment of disease
|
|
EP2781507B1
(en)
|
2011-11-18 |
2017-03-22 |
Nof Corporation |
Cationic lipid having improved intracellular kinetics
|
|
US20140308304A1
(en)
|
2011-12-07 |
2014-10-16 |
Alnylam Pharmaceuticals, Inc. |
Lipids for the delivery of active agents
|
|
JP6305343B2
(ja)
|
2011-12-07 |
2018-04-04 |
アルニラム・ファーマシューティカルズ・インコーポレーテッド |
活性薬剤の送達のための分岐アルキルおよびシクロアルキルを末端とする生分解性脂質
|
|
EP3988537A1
(en)
|
2011-12-07 |
2022-04-27 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
EP2792367A4
(en)
|
2011-12-12 |
2015-09-30 |
Kyowa Hakko Kirin Co Ltd |
LIPID NANOPARTICLES FOR A DRUG DELIVERY SYSTEM CONTAINING CATIONIC LIPIDS
|
|
WO2013116126A1
(en)
|
2012-02-01 |
2013-08-08 |
Merck Sharp & Dohme Corp. |
Novel low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
|
|
NZ700075A
(en)
|
2012-02-24 |
2016-05-27 |
Protiva Biotherapeutics Inc |
Trialkyl cationic lipids and methods of use thereof
|
|
US9446132B2
(en)
|
2012-03-27 |
2016-09-20 |
Sima Therapeutics, Inc. |
Diether based biodegradable cationic lipids for siRNA delivery
|
|
KR102255108B1
(ko)
|
2013-03-08 |
2021-05-24 |
노파르티스 아게 |
활성제의 전달을 위한 지질 및 지질 조성물
|
|
AU2014265608B2
(en)
|
2013-05-15 |
2018-12-20 |
Robert Kruse |
Intracellular translation of circular RNA
|
|
WO2015011633A1
(en)
|
2013-07-23 |
2015-01-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
|
EP3041938A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
WO2015061467A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Lipid formulations for delivery of messenger rna
|
|
US9593077B2
(en)
|
2013-11-18 |
2017-03-14 |
Arcturus Therapeutics, Inc. |
Ionizable cationic lipid for RNA delivery
|
|
EP3071515A2
(en)
|
2013-11-18 |
2016-09-28 |
Rubius Therapeutics, Inc. |
Synthetic membrane-receiver complexes
|
|
US9365610B2
(en)
|
2013-11-18 |
2016-06-14 |
Arcturus Therapeutics, Inc. |
Asymmetric ionizable cationic lipid for RNA delivery
|
|
EP3623361B1
(en)
|
2013-12-19 |
2021-08-18 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
ES2908827T3
(es)
|
2013-12-19 |
2022-05-04 |
Novartis Ag |
Lípidos y composiciones lipídicas para el suministro de agentes activos
|
|
HUE054471T2
(hu)
|
2014-04-01 |
2021-09-28 |
Rubius Therapeutics Inc |
Immunmodulációs módszerek és készítmények
|
|
IL289934B2
(en)
|
2014-06-25 |
2023-04-01 |
Acuitas Therapeutics Inc |
Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
US10407683B2
(en)
|
2014-07-16 |
2019-09-10 |
Modernatx, Inc. |
Circular polynucleotides
|
|
WO2016183482A1
(en)
|
2015-05-13 |
2016-11-17 |
Rubius Therapeutics, Inc. |
Membrane-receiver complex therapeutics
|
|
EP3303377B1
(en)
|
2015-06-05 |
2022-11-23 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for transient gene therapy with enhanced stability
|
|
CA2990172A1
(en)
|
2015-06-19 |
2016-12-22 |
Massachusetts Institute Of Technology |
Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
|
|
CN114085198A
(zh)
|
2015-06-29 |
2022-02-25 |
爱康泰生治疗公司 |
用于递送核酸的脂质和脂质纳米颗粒制剂
|
|
CA3029602A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Louisville Research Foundation, Inc. |
Edible plant-derived microvesicle compositions for delivery of mirna and methods for treatment of cancer
|
|
EP3350157B1
(en)
|
2015-09-17 |
2022-01-05 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
RS63986B1
(sr)
|
2015-10-28 |
2023-03-31 |
Acuitas Therapeutics Inc |
Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
|
|
ES2924407T3
(es)
|
2015-12-10 |
2022-10-06 |
Modernatx Inc |
Composiciones y procedimientos para el suministro de agentes terapéuticos
|
|
WO2017117528A1
(en)
|
2015-12-30 |
2017-07-06 |
Acuitas Therapeutics, Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
MX2018008515A
(es)
|
2016-01-11 |
2019-05-09 |
Rubius Therapeutics Inc |
Composiciones y metodos relacionados con sistemas celulares terapeuticos multimodales para indicaciones inmunitarias.
|
|
SMT202500211T1
(it)
|
2016-03-30 |
2025-07-22 |
Intellia Therapeutics Inc |
Formulazioni di nanoparticelle lipidiche per componenti crispr/cas
|
|
WO2018009838A1
(en)
|
2016-07-07 |
2018-01-11 |
Rubius Therapeutics, Inc. |
Compositions and methods related to therapeutic cell systems expressing exogenous rna
|
|
EP4714454A2
(en)
|
2016-10-26 |
2026-03-25 |
Acuitas Therapeutics Inc. |
Lipid nanoparticle formulations
|
|
RU2019120400A
(ru)
|
2016-12-02 |
2021-01-11 |
Рубиус Терапьютикс, Инк. |
Композиции и способы, связанные с клеточными системами для проникновения в солидные опухоли
|
|
CN110520522A
(zh)
|
2017-02-17 |
2019-11-29 |
鲁比厄斯治疗法股份有限公司 |
功能化红系细胞
|
|
KR20250021608A
(ko)
|
2017-05-08 |
2025-02-13 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
막 융합을 촉진시키기 위한 조성물 및 그의 용도
|
|
SG11202000765PA
(en)
|
2017-09-08 |
2020-03-30 |
Generation Bio Co |
Lipid nanoparticle formulations of non-viral, capsid-free dna vectors
|
|
KR20250093420A
(ko)
|
2017-09-29 |
2025-06-24 |
인텔리아 테라퓨틱스, 인크. |
게놈 편집을 위한 폴리뉴클레오티드, 조성물 및 방법
|
|
HUE066630T2
(hu)
|
2017-09-29 |
2024-08-28 |
Intellia Therapeutics Inc |
Készítmények
|
|
BR112020011670A2
(pt)
|
2017-12-15 |
2020-11-17 |
Flagship Pioneering Innovations Vi, Llc. |
composições compreendendo polirribonucleotídeos circulares e seus usos
|
|
EP3790964A4
(en)
|
2018-05-11 |
2022-06-08 |
Beam Therapeutics, Inc. |
METHODS FOR REMOVAL OF PATHOGENIC MUTATIONS USING PROGRAMMABLE BASE EDITOR SYSTEMS
|
|
EP3801639A1
(en)
*
|
2018-06-06 |
2021-04-14 |
Massachusetts Institute of Technology |
Circular rna for translation in eukaryotic cells
|
|
SG11202100750XA
(en)
|
2018-07-24 |
2021-02-25 |
Flagship Pioneering Innovations Vi Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
AR116016A1
(es)
|
2018-08-24 |
2021-03-25 |
Flagship Pioneering Innovations Vi Llc |
Métodos para fabricar paquetes mensajeros vegetales
|
|
WO2020047124A1
(en)
|
2018-08-28 |
2020-03-05 |
Flagship Pioneering, Inc. |
Methods and compositions for modulating a genome
|
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
AU2019361129A1
(en)
|
2018-10-18 |
2021-05-20 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
|
MX2021005969A
(es)
|
2018-11-21 |
2021-09-14 |
Translate Bio Inc |
Tratamiento de la fibrosis quística mediante el suministro de arnm que codifica cftr nebulizado.
|
|
MA55083A
(fr)
|
2019-03-01 |
2022-03-16 |
Flagship Pioneering Innovations Vi Llc |
Polyribonucléotides et leurs utilisations cosmétiques
|
|
KR20210134716A
(ko)
|
2019-03-01 |
2021-11-10 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
폴리리보뉴클레오티드의 전달을 위한 조성물, 방법, 및 키트
|
|
AU2020233404A1
(en)
*
|
2019-03-04 |
2021-09-16 |
Flagship Pioneering Innovations Vi, Llc |
Circular polyribonucleotides and pharmaceutical compositions thereof
|
|
CN115806976A
(zh)
|
2019-03-20 |
2023-03-17 |
中国科学院上海营养与健康研究所 |
利用环形rna进行蛋白翻译及其应用
|
|
CA3131319A1
(en)
*
|
2019-03-25 |
2020-10-01 |
Avak Kahvejian |
Compositions comprising modified circular polyribonucleotides and uses thereof
|
|
AU2020261419B2
(en)
|
2019-04-25 |
2026-01-29 |
Intellia Therapeutics, Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
AU2020280105A1
(en)
|
2019-05-22 |
2022-01-20 |
Massachusetts Institute Of Technology |
Circular RNA compositions and methods
|
|
US20220257794A1
(en)
|
2019-06-14 |
2022-08-18 |
Flagship Pioneering Innovations Vi, Llc |
Circular rnas for cellular therapy
|
|
US20220305128A1
(en)
|
2019-06-19 |
2022-09-29 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides for protein modulation and uses thereof
|
|
WO2020257727A1
(en)
|
2019-06-19 |
2020-12-24 |
Flagship Pioneering Innovations Vi, Llc |
Methods of dosing circular polyribonucleotides
|
|
US20220288176A1
(en)
|
2019-08-28 |
2022-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circular rna modification and methods of use
|
|
JP2023504568A
(ja)
|
2019-12-04 |
2023-02-03 |
オルナ セラピューティクス インコーポレイテッド |
環状ｒｎａ組成物及び方法
|
|
CA3168840A1
(en)
|
2020-02-04 |
2021-08-12 |
Duke University |
Compositions and methods for circular rna expression
|
|
WO2021236855A1
(en)
|
2020-05-19 |
2021-11-25 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
JP2023526422A
(ja)
|
2020-05-20 |
2023-06-21 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
コロナウイルス抗原組成物及びそれらの使用
|
|
EP4153223A1
(en)
|
2020-05-20 |
2023-03-29 |
Flagship Pioneering Innovations VI, LLC |
Immunogenic compositions and uses thereof
|
|
CN116635525A
(zh)
|
2020-08-21 |
2023-08-22 |
北京大学 |
环状rna疫苗及其使用方法
|
|
MX2023002439A
(es)
|
2020-09-03 |
2023-05-09 |
Flagship Pioneering Innovations Vi Llc |
Composiciones immunogénicas y usos de las mismas.
|
|
JP2024523054A
(ja)
|
2021-05-18 |
2024-06-26 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
環状ポリリボヌクレオチドを濃縮する方法
|
|
EP4341424A1
(en)
|
2021-05-18 |
2024-03-27 |
Flagship Pioneering Innovations VI, LLC |
Methods of enriching for circular polyribonucleotides
|
|
CN115404240A
(zh)
|
2021-05-28 |
2022-11-29 |
上海环码生物医药有限公司 |
制备环形rna的构建体、方法及其用途
|
|
IL308746A
(en)
|
2021-06-10 |
2024-03-01 |
Orna Therapeutics Inc |
Cyclic RNA compositions and methods
|
|
JP2024528875A
(ja)
|
2021-07-27 |
2024-08-01 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
処理のための装置、システム及び方法
|